FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, namely to development of an anticancer drug. The anticancer drug exhibiting HT-29 and DLD-1 bowel cancer cell activity is presented by a dry extract of Amur maackia heartwood.
EFFECT: drug extends the range of anticancer agents active in relation to HT-29 and DLD-1 bowel cancer cells.
3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TORK PROTEIN KINASE INHIBITOR WITH DIRECTED CHEMOPREVENTIVE EFFECT IN VITRO | 2014 |
|
RU2566268C1 |
HEPATOPROTECTIVE AGENT | 2003 |
|
RU2244553C1 |
AGENT PREVENTING MAMMAL NORMAL CELL TRANSFORMATION IN MALIGNANT CELLS | 2010 |
|
RU2429840C1 |
ANTIVIRAL AGENT AGAINST HUMAN HERPESVIRUS TYPE I AND ENTEROVIRUS B | 2022 |
|
RU2798659C1 |
ANTIMENOPAUSAL DRUG | 2009 |
|
RU2398592C1 |
AGENT PREVENTING MAMMAL NORMAL CELL TRANSFORMATION IN MALIGNANT CELLS | 2010 |
|
RU2429839C1 |
AN ANTIVIRAL AGENT AGAINST SARS-COV-2 CORONAVIRUS | 2022 |
|
RU2788762C1 |
METHOD OF PRODUCING POLYPHENOL COMPLEX FROM AMUR MAACKIA HEARTWOOD | 2023 |
|
RU2822249C1 |
THERAPEUTIC QUINONES | 2005 |
|
RU2411229C2 |
HEPATOPROTECTOR | 2011 |
|
RU2454243C1 |
Authors
Dates
2011-03-27—Published
2009-12-01—Filed